BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 7915666)

  • 1. Torsades de pointes induced by nonantiarrhythmic drugs.
    Tran HT
    Conn Med; 1994 May; 58(5):291-5. PubMed ID: 7915666
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Torsade de pointes due to noncardiac drugs: most patients have easily identifiable risk factors.
    Zeltser D; Justo D; Halkin A; Prokhorov V; Heller K; Viskin S
    Medicine (Baltimore); 2003 Jul; 82(4):282-90. PubMed ID: 12861106
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Torsades de pointe with spiramycine and metiquazine therapy. Apropos of a case].
    Verdun F; Mansourati J; Jobic Y; Bouquin V; Munier S; Guillo P; Pagès Y; Boschat J; Blanc JJ
    Arch Mal Coeur Vaiss; 1997 Jan; 90(1):103-6. PubMed ID: 9137721
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Second-generation antihistamines: the risk of ventricular arrhythmias.
    DuBuske LM
    Clin Ther; 1999 Feb; 21(2):281-95. PubMed ID: 10211532
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Safety of non-antiarrhythmic drugs that prolong the QT interval or induce torsade de pointes: an overview.
    De Ponti F; Poluzzi E; Cavalli A; Recanatini M; Montanaro N
    Drug Saf; 2002; 25(4):263-86. PubMed ID: 11994029
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Erythromycin and ketoconazole (Nizoral) associated with terfenadine (Seldane)-induced ventricular arrhythmias.
    Wynn RL
    Gen Dent; 1993; 41(1):27-9. PubMed ID: 7489857
    [No Abstract]   [Full Text] [Related]  

  • 7. QT prolongation and development of torsades de pointes with the concomitant administration of oral erythromycin base and quinidine.
    Lin JC; Quasny HA
    Pharmacotherapy; 1997; 17(3):626-30. PubMed ID: 9165570
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Combined use of astemizole and ketoconazole resulting in torsade de pointes.
    Tsai WC; Tsai LM; Chen JH
    J Formos Med Assoc; 1997 Feb; 96(2):144-6. PubMed ID: 9071844
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cardiovascular toxicity of antihistamines.
    Smith SJ
    Otolaryngol Head Neck Surg; 1994 Sep; 111(3 Pt 2):348-54. PubMed ID: 7916150
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Torsades de pointes occurring in association with terfenadine use.
    Monahan BP; Ferguson CL; Killeavy ES; Lloyd BK; Troy J; Cantilena LR
    JAMA; 1990 Dec; 264(21):2788-90. PubMed ID: 1977935
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Risk of torsades de pointes with non-cardiac drugs. Doctors need to be aware that many drugs can cause qt prolongation.
    Yap YG; Camm J
    BMJ; 2000 Apr; 320(7243):1158-9. PubMed ID: 10784527
    [No Abstract]   [Full Text] [Related]  

  • 12. Predictors of torsades de pointes in rabbit ventricles perfused with sedating and nonsedating histamine H1-receptor antagonists.
    Gilbert JD; Cahill SA; McCartney DG; Lukas A; Gross GJ
    Can J Physiol Pharmacol; 2000 May; 78(5):407-14. PubMed ID: 10841436
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Frequency of high-risk use of QT-prolonging medications.
    Allen LaPointe NM; Curtis LH; Chan KA; Kramer JM; Lafata JE; Gurwitz JH; Raebel MA; Platt R
    Pharmacoepidemiol Drug Saf; 2006 Jun; 15(6):361-8. PubMed ID: 16178046
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Long QT-syndrome as a drug-induced side effect].
    Pohjola-Sintonen S
    Duodecim; 1998; 114(19):1891, 1893, 1895. PubMed ID: 11717743
    [No Abstract]   [Full Text] [Related]  

  • 15. Divergent proarrhythmic potential of macrolide antibiotics despite similar QT prolongation: fast phase 3 repolarization prevents early afterdepolarizations and torsade de pointes.
    Milberg P; Eckardt L; Bruns HJ; Biertz J; Ramtin S; Reinsch N; Fleischer D; Kirchhof P; Fabritz L; Breithardt G; Haverkamp W
    J Pharmacol Exp Ther; 2002 Oct; 303(1):218-25. PubMed ID: 12235254
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Drug-induced arrhythmias].
    Mizumaki K; Inoue H
    Nihon Rinsho; 2002 Jul; 60(7):1449-55. PubMed ID: 12136628
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Drug-induced torsades de pointes in one patient with congenital long QT syndrome.
    Hsieh MH; Chen SA; Chiang CE; Tai CT; Lee SH; Wen ZC; Chang MS
    Int J Cardiol; 1996 Apr; 54(1):85-8. PubMed ID: 8792191
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Drug-induced q-T prolongation.
    Kao LW; Furbee RB
    Med Clin North Am; 2005 Nov; 89(6):1125-44, x. PubMed ID: 16227057
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cardiac actions of antihistamines.
    Woosley RL
    Annu Rev Pharmacol Toxicol; 1996; 36():233-52. PubMed ID: 8725389
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long QT syndrome caused by noncardiac drugs.
    Viskin S; Justo D; Halkin A; Zeltser D
    Prog Cardiovasc Dis; 2003; 45(5):415-27. PubMed ID: 12704598
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.